Health Care [ 8/12 ] | Pharmaceuticals [ 29/76 ]
NASDAQ | Common Stock
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines in the United States and Canada.
It offers CARDAMYST (etripamil) nasal spray, a prescription medication for the conversion of acute symptomatic episodes of paroxysmal supraventricular tachycardia (PSVT) to sinus rhythm in adults.
The company is also developing etripamil for the indication of atrial fibrillation with rapid ventricular rate (AFib-RVR).
It has a license and collaboration agreement with Corxel Pharmaceuticals to develop and commercialize etripamil.
Milestone Pharmaceuticals Inc.was incorporated in 2003 and is headquartered in Montreal, Canada.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Mar 31, 26 | -0.15 Increased by +21.05% | -0.16 Increased by +6.25% |
| Nov 12, 25 | -0.12 Increased by +15.85% | -0.16 Increased by +25.00% |
| Aug 12, 25 | -0.20 Decreased by -42.86% | -0.18 Decreased by -11.11% |
| May 12, 25 | -0.31 Decreased by -47.62% | -0.20 Decreased by -58.97% |
| Mar 19, 25 | -0.19 Increased by +40.63% | -0.15 Decreased by -26.67% |
| Nov 11, 24 | -0.14 Increased by +59.26% | -0.16 Increased by +10.87% |
| Aug 8, 24 | -0.14 Increased by +62.16% | -0.19 Increased by +26.32% |
| May 13, 24 | -0.21 Increased by +40.00% | -0.26 Increased by +19.23% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Dec 31, 25 | 1.55 M Increased by +1.33 K% | -17.41 M Decreased by -40.82% | Decreased by -1.13 K% Increased by +90.16% |
| Sep 30, 25 | 0.00 Decreased by N/A% | -11.92 M Decreased by -26.31% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 25 | 0.00 Decreased by N/A% | -12.97 M Decreased by -38.48% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 25 | 0.00 Increased by +100.00% | -20.76 M Decreased by -100.51% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 24 | 108.00 K Increased by +112.44% | -12.36 M Increased by +9.17% | Decreased by -11.45 K% Decreased by -830.01% |
| Sep 30, 24 | 0.00 Decreased by N/A% | -9.44 M Increased by +37.41% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 24 | 0.00 Decreased by N/A% | -9.36 M Increased by +41.64% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 24 | -868.00 K Decreased by -186.80% | -10.35 M Increased by +30.74% | Increased by +1.19 K% Increased by +179.79% |